Michael B Gatch
Overview
Explore the profile of Michael B Gatch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gatch M, Forster M
Neurotoxicology
. 2018 Nov;
70:72-79.
PMID: 30439379
A new generation of novel cannabinoid compounds have been developed as marijuana substitutes to avoid drug control laws and cannabinoid blood tests. 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA,...
12.
Dolan S, Shetty R, Forster M, Gatch M
J Psychopharmacol
. 2018 Jun;
32(7):802-810.
PMID: 29909719
Background: Substituted piperazines comprise a substantial proportion of the novel psychoactive substance market. Among the most widely abused piperazine compounds are meta-chlorophenylpiperazine (mCPP), tri-fluoromethylphenylpiperazine (TFMPP), and, especially, benzylpiperazine (BZP), which...
13.
Baladi M, Forster M, Gatch M, Mailman R, Hyman D, Carter L, et al.
J Pharmacol Exp Ther
. 2018 Jun;
366(2):367-376.
PMID: 29891587
Excessive sleepiness (ES) is associated with several sleep disorders, including narcolepsy and obstructive sleep apnea (OSA). A role for monoaminergic systems in treating these conditions is highlighted by the clinical...
14.
Dolan S, Chen Z, Huang R, Gatch M
Neuropharmacology
. 2018 Jan;
133:171-180.
PMID: 29378213
This study aimed to address the mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA commonly reported in "Ecstasy" formulations: methylone, butylone, and pentylone. Whole-cell patch clamp techniques...
15.
Gatch M, Forster M
Psychopharmacology (Berl)
. 2017 Nov;
235(3):673-680.
PMID: 29138877
Rationale And Objectives: Novel synthetic cannabinoid compounds continue to appear in the market advertised as legal alternatives to marijuana and the older synthetic cannabinoid compounds which are now controlled substances....
16.
Dolan S, Forster M, Gatch M
Drug Alcohol Depend
. 2017 Sep;
180:39-45.
PMID: 28865391
Novel psychoactive substances have maintained a prominent role in the global drug culture, despite increased regulation by governing bodies. Novel compounds continue to become available on the market, often in...
17.
Gatch M, Dolan S, Forster M
Behav Pharmacol
. 2017 May;
28(5):375-385.
PMID: 28537942
There has been increasing use of novel synthetic hallucinogenic compounds, 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25B-NBOMe), 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25C-NBOMe), 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25I-NBOMe), and N,N-diallyl-5-methoxy tryptamine (5-MeO-DALT), which have been associated with severe toxicities....
18.
Gatch M, Dolan S, Forster M
Psychopharmacology (Berl)
. 2017 Feb;
234(8):1237-1245.
PMID: 28210779
Rationale: Recent years have seen an increase in the recreational use of novel, synthetic psychoactive substances. There are little or no data on the abuse liability of many of the...
19.
Carbonaro T, Gatch M
Brain Res Bull
. 2016 Apr;
126(Pt 1):74-88.
PMID: 27126737
N,N-dimethyltryptamine (DMT) is an indole alkaloid widely found in plants and animals. It is best known for producing brief and intense psychedelic effects when ingested. Increasing evidence suggests that endogenous...
20.
Gatch M, Dolan S, Forster M
Behav Pharmacol
. 2016 Mar;
27(6):497-505.
PMID: 27028902
5,6-Methylenedioxy-2-aminoindane (MDAI) has become a common substitute for (±)-3,4-methylenedioxymethamphetamine (MDMA) in Ecstasy. MDAI is known to produce MDMA-like discriminative stimulus effects, but it is not known whether MDAI has psychostimulant...